skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Reading the press release regarding SIS increasing its dividend, the president stated "Considering the aging population and its desire to age at home, we expect continued growth of over 10% in our lift division over the next five years and we maintain our objective to generate revenue of some $500 million by the end of 2021," concluded Mr. Bourassa.
With 2016-12 revenue at 120 million, that is a 4x revenue increase in 5 years. Very promising. How would you calculate the market cap and share price in 5 years based on his 5 year objective?
Read Answer Asked by Curtis on September 12, 2017
Q: hello 5i:
I am normally a fairly risk averse investor. Butttttt, knowing that the key person is probably the most important ingredient in a company, and assuming the company has a product that is still relevant (we'll rule out typewriters and horse drawn buggies), I am more than willing to have a small part of our portfolio in a growth company with good earnings potential. ie, we are invested in GUD, primarily because of Jonathan Goodman.
Recently, I've read about a company called Synergy CHC, run by a man called Jack Ross. Mr Ross is a very major shareholder in SNYR. And Knight (GUD) has invested in SNYR, something I see as a vote of confidence from Mr Goodman.
Knowing its not your forte, but trying to do my due diligence, can I ask you to comment on this company? I would try to establish a position at $XXX as it seems to be a thin trader, and fairly volatile. But I can't access this name on Stockcharts, so am a little constrained with TA. And there is not much information, in general, available.
Any advice you can give is beneficial
note that you can publish all of this question, EXCEPT FOR the part about my (hopeful) offer price.
tia
Paul L
Read Answer Asked by Paul on September 11, 2017
Q: Hello team,

Would you buy this company at this time? Is its massive/nonstop share price growth really justified? Isn't there any competition out there for it? What are the pitfalls in your opinion? What do you think about its mid-/long-term prospects?

Thanks for your exemplary insights as always!
Read Answer Asked by Saeed on September 11, 2017
Q: Greetings 5i,

I am making an effort to increase my exposure to US stocks, and am considering adding a US healthcare position to augment my Canadian healthcare holdings of CSH.UN and GUD.

JNJ was my first thought, given its strong history, massive valuation, and diversification. However, I am (like many, I assume) concerned about its legal troubles; particularly given the severity of the issues that surround them. Moreover, it appears that said troubles may be present for quite a long time.

I am thinking long term (I am 36), am a "buy and hold" investor, and will not need the capital I would be deploying for the foreseeable future.

Do you feel as if this is a good entry point for JNJ (perhaps a half position to start), or would you wait to see how the legal situations unfold before considering this purchase? If the latter, is there another American healthcare stock you might recommend in its place?

Thank you.
Read Answer Asked by Lucas on September 07, 2017
Q: GUD is consistently a top recommendation as a growth stock. Have you spoken with GUD mgmt. lately to be able provide any additional info. as to when/how they are expecting to invest some of their cash and therefore move the stock in the next six months?
Without any news, it seems that GUD will continue to drift down as the 'bored' investors continue to sell.
Read Answer Asked by Curtis on September 05, 2017
Q: Good morning,

With sells as it was going up, I am still about breakeven on CRH but it has dropped to 1% of my portfolio. I have lost confidence such that I won't put more in. I am, however, looking for additional healthcare exposure. Right now I am also holding JNJ (3%) Danaher (DHR, 4%) which is mostly medical/dental since the spin-off of Fortive. I have been thinking of exiting JNJ due to the price that they paid for their latest acquisition. It seems a little inconsistent with their historically very conservative nature.

Would you think that adding a 2.5-3% SIS or GUD is a better approach, or should I keep CRH given its longer term potential? I prefer to not watch my investments every day and have a diversified portfolio across market cap and Canada/US with a lot of multinational companies (like CCL in Canada and UL in the US, for instance).

Do you have any perspective on the JNJ acquisition? If so, please feel free to deduct two questions.

Thanks!

Derek
Read Answer Asked by Derek on September 05, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!